GlaxoSmithKline is set to name Philip Hampton as its next chairman, according to people familiar with the matter—a move that while widely expected comes as the pharmaceuticals giant struggles to right itself amid a series of probes over alleged overseas bribery.
via WSJ.com: US Business http://ift.tt/1vhuJXk
via WSJ.com: US Business http://ift.tt/1vhuJXk
Nessun commento:
Posta un commento